Epcoritamab Treatment for DLBCL Progression

Created using ChatSlide

This presentation will delve into the role of Epcoritamab in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL), offering insights from the perspective of healthcare expertise. Focusing on patient history, initial diagnoses, and the challenges of relapsed cases, we will explore the evolution of treatment strategies, including the impact of CAR-T therapy. The session will provide current hospitalization details, emphasizing the clinical progression and strategic use of Epcoritamab. We will...